Adult RA patients been using ADM (40 mg every other week) for >1 year and had LDA (DAS28 < 3.2, or the rheumatologist’s assessment of LDA with CRP <10 mg/L) for at least 6 months, stopped ADM treatment. This evidence concerns the gene CRP and rheumatoid arthritis.